Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain

Summary

This study is designed to develop our understanding of the risk-benefit of using lumiracoxib in patients with acute musculoskeletal pain due to uncomplicated soft tissue injury.

Timeline

Start

2004-11

Primary completion

—

Completion

—

Publications

• Kyle C, Zachariah J, Kinch H, Ellis G, Andrews C, Adekunle F. A randomised, double-blind study comparing lumiracoxib with naproxen for acute musculoskeletal pain. Int J Clin Pract. 2008 Nov;62(11):1684-92. doi: 10.1111/j.1742-1241.2008.01906.x.

Drugs

Indications